Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

TY - JOUR

T1 - Reader response

T2 - Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

AU - Avasarala, Jagannadha

PY - 2018/9/18

Y1 - 2018/9/18

UR - https://www.scopus.com/pages/publications/85071353740

UR - https://www.scopus.com/pages/publications/85071353740#tab=citedBy

U2 - 10.1212/01.wnl.0000544324.09014.0e

DO - 10.1212/01.wnl.0000544324.09014.0e

M3 - Comment/debate

C2 - 30224507

AN - SCOPUS:85071353740

SN - 0028-3878

VL - 91

SP - 580

JO - Neurology

JF - Neurology

IS - 12

ER -